Core Viewpoint - Septerna, Inc. is a clinical-stage biotechnology company focused on G protein-coupled receptor (GPCR) drug discovery and will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 [1] Group 1: Company Overview - Septerna, Inc. is advancing GPCR therapies to address significant unmet medical needs [3] - The company utilizes its proprietary Native Complex Platform® to enhance GPCR drug discovery [3] - Septerna has developed a diverse pipeline of novel oral small molecule drug candidates targeting various therapeutic areas including endocrinology, immunology, inflammation, and metabolic diseases [3] Group 2: Presentation Details - Jeffrey Finer, M.D., Ph.D., CEO and co-founder of Septerna, will present at the conference at 3:10 p.m. ET [1] - A live webcast of the presentation will be available on the company's website and archived for at least 30 days [2]